Which of the following is a selective estrogen receptor modulator (SERM)?
**Core Concept**
Selective estrogen receptor modulators (SERMs) are a class of compounds that act on the estrogen receptor (ER) to produce tissue-specific agonist or antagonist effects. SERMs bind to the estrogen receptor, but their effects vary depending on the tissue type, leading to either estrogenic or anti-estrogenic effects.
**Why the Correct Answer is Right**
Raloxifene is a well-known SERM that is used primarily for the prevention and treatment of osteoporosis in postmenopausal women. It acts by binding to the estrogen receptor, which in turn modulates the transcription of estrogen-responsive genes. In bone tissue, raloxifene acts as an estrogen agonist, increasing bone density, while in breast tissue, it acts as an estrogen antagonist, reducing the risk of breast cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** Tamoxifen is a SERM, but it is primarily used in the treatment and prevention of breast cancer, whereas raloxifene is used for osteoporosis prevention.
**Option B:** Clomiphene is a SERM, but it is used for ovulation induction in infertility treatment, and its mechanism of action is different from raloxifene.
**Option C:** Toremifene is another SERM, but it is used for the treatment of breast cancer, and its effects are more pronounced in breast tissue compared to raloxifene.
**Clinical Pearl / High-Yield Fact**
SERMs are a valuable class of compounds in clinical practice, offering targeted therapy for various conditions, including osteoporosis, breast cancer, and infertility. Understanding the tissue-specific effects of SERMs is crucial for their effective use in patient management.
**Correct Answer: C. Toremifene.**